AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsitePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-680632 is the first representative of a new class of Aurora inhibitors with a high potential for further development as an anticancer therapeutic.
More Information Supplier PagePHA-767491 is a potent, ATP-competitive dual cdc7/cdk9 inhibitor (IC50 values are 10 and 34 nM respectively) that prevents initiation of DNA replication.
More Information Supplier PagePHA-767491 is a potent, ATP-competitive dual cdc7/cdk9 inhibitor (IC50 values are 10 and 34 nM respectively) that prevents initiation of DNA replication.
More Information Supplier PagePHA-767491 is a potent, ATP-competitive dual cdc7/cdk9 inhibitor (IC50 values are 10 and 34 nM respectively) that prevents initiation of DNA replication.
More Information Supplier PagePHA-767491 is a potent, ATP-competitive dual cdc7/cdk9 inhibitor (IC50 values are 10 and 34 nM respectively) that prevents initiation of DNA replication.
More Information Supplier PagePHA-793887, a novel potent inhibitor of Cdk, target on kinds of cyclin-dependent kinase under low concentrations and poses high activity against several cancer cell lines.
More Information Supplier PagePHA-793887, a novel potent inhibitor of Cdk, target on kinds of cyclin-dependent kinase under low concentrations and poses high activity against several cancer cell lines.
More Information Supplier PagePHA-793887, a novel potent inhibitor of Cdk, target on kinds of cyclin-dependent kinase under low concentrations and poses high activity against several cancer cell lines.
More Information Supplier PagePHA-793887, a novel potent inhibitor of Cdk, target on kinds of cyclin-dependent kinase under low concentrations and poses high activity against several cancer cell lines.
More Information Supplier PagePHA-793887, a novel potent inhibitor of Cdk, target on kinds of cyclin-dependent kinase under low concentrations and poses high activity against several cancer cell lines.
More Information Supplier PagePHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.
More Information Supplier PagePHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.
More Information Supplier PagePHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.
More Information Supplier PagePHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.
More Information Supplier PagePHA-848125 (Milciclib) is an orally bioavailable inhibitor of CDKs and TRKA with potential antineoplastic activity.
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier PagePhellodendrine is an alkaloid isolated originally from Phellodendron amurense.
More Information Supplier PagePhellodendrine is an alkaloid isolated originally from Phellodendron amurense.
More Information Supplier PagePhellodendrine is an alkaloid isolated originally from Phellodendron amurense.
More Information Supplier PagePhellodendrine chloride, exhibits immunosuppressive and anti-inflammatory activities.
More Information Supplier PagePhellodendrine chloride, exhibits immunosuppressive and anti-inflammatory activities.
More Information Supplier PagePhellodendrine chloride, exhibits immunosuppressive and anti-inflammatory activities.
More Information Supplier PagePhenacetin is a non-opioid analgesic without anti-inflammatory properties.
More Information Supplier PagePhenacetin is a non-opioid analgesic without anti-inflammatory properties.
More Information Supplier PagePhenazepam is a benzodiazepine agonist of the ??-aminobutyric acid A (GABAA)-benzodiazepine receptor chloride channel complex.
More Information Supplier PagePhenazepam is a benzodiazepine agonist of the ??-aminobutyric acid A (GABAA)-benzodiazepine receptor chloride channel complex.
More Information Supplier PagePhenazepam is a benzodiazepine agonist of the ??-aminobutyric acid A (GABAA)-benzodiazepine receptor chloride channel complex.
More Information Supplier PagePhenazepam is a benzodiazepine agonist of the ??-aminobutyric acid A (GABAA)-benzodiazepine receptor chloride channel complex.
More Information Supplier PagePhenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
More Information Supplier PagePhenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
More Information Supplier PagePhenformin hydrochloride is a hydrochloride salt of phenformin from the biguanide drug class that displays anti-diabetic activity.
More Information Supplier PagePhenoxybenzamine is a cell-permeable, non-specific, irreversible ??-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
More Information Supplier PagePhenoxybenzamine is a cell-permeable, non-specific, irreversible ??-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
More Information Supplier PagePhenoxybenzamine is a cell-permeable, non-specific, irreversible ??-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
More Information Supplier PagePhenoxybenzamine is a cell-permeable, non-specific, irreversible ??-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
More Information Supplier PagePhenoxybenzamine is a cell-permeable, non-specific, irreversible ??-adrenergic (AR) antagonist that also acts as an CaM inhibitor.
More Information Supplier PagePhenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).
More Information Supplier PagePhenprocoumon is a vitamin K antagonist that inhibits coagulation by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders (thrombosis/pulmonary embolism).
More Information Supplier Page
